VANI - Vivani Medical, Inc.
Region: US
Website: vivani.com
Employees: 20
IPO year: 2011
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Second Sight Medical Products, Inc. develops implantable visual prosthetics intended to deliver artificial vision to blind individuals. Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, is intended to provide useful artificial vision. The company was founded in 1998 and is headquartered in Sylmar, California.
Vivani Medical: Q4 Earnings Snapshot
ALAMEDA, Calif. AP) — Vivani Medical, Inc. VANI) on Monday reported a loss of $6.1 million in its fourth quarter.
Read moreVivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Successful initial administration and full enrollment in first-in-human LIBERATE-1™ study of NPM-115 (exenatide implant) in obese and overweight subjects with top-line data expected in mid-2025 Positive NPM-139 (semaglutide implant) preclinical weight loss data comparable to injections of semaglutide, active ingredient in Ozempic®/Wegovy®, with potential for once-yearly dosing Additional $8.25M equity financing which secures solid financial position into the second quarter of 2026, supporting fu
Read moreVivani Medical Announces $8.25M Private Placement Equity Financing
Financing strengthens balance sheet, extending expected runway into the second quarter of 2026 Enables accelerated development of NPM-139, Company’s once or twice-yearly GLP-1 (semaglutide) implant under development for chronic weight management ALAMEDA, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced that it has entered int
Read more